Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Pediatrics/Neonatology | Neurology
Disease Category: Autism
Trial Information
Clinical trial to test a study drug in Children and Adolescents with Autistic Disorder
The purpose of this research study is to evaluate 2 dose levels
of the study drug for irritability and related behaviors associated
with Autistic Disorder in children and adolescents.
Study drug and study procedures will be made available to you at
no cost.
To qualify, you child/adolescent must:
- Be at least 5 to 17 years old
- Be at least 44lbs
You will not qualify if your
child/adolescent:
- Is pregnant or breast-feeding
- Has a history of prior or current DSM-IV psychotic disorder
(e.g., schizophrenia, bipolar disorder, other psychosis).
- Has received an experimental drug or used an experimental
medical device within 3 months before the planned start of
treatment
Linda Spritzer, Research Coordinator
Biomedical Research Alliance of New York
North Shore-Long Island Jewish Health System
Fay J. Lindner Center for Autism and Developmental Disorders
4300 Hempstead Turnpike
Bethpage, NY 11714
Phone: 516-802-8608
EMail: lspritze@nshs.edu
View Google Map
If you would like to learn more about participating in this study, please send an e-mail message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these
trials.
